CRETELLA, DANIELE
 Distribuzione geografica
Continente #
EU - Europa 171
NA - Nord America 71
AS - Asia 29
AF - Africa 3
Totale 274
Nazione #
IT - Italia 75
US - Stati Uniti d'America 71
IE - Irlanda 46
FR - Francia 22
DE - Germania 8
IN - India 8
CN - Cina 6
GB - Regno Unito 5
NL - Olanda 5
VN - Vietnam 5
FI - Finlandia 3
JP - Giappone 3
AT - Austria 2
HK - Hong Kong 2
KR - Corea 2
SC - Seychelles 2
CZ - Repubblica Ceca 1
HU - Ungheria 1
IR - Iran 1
NO - Norvegia 1
SA - Arabia Saudita 1
SE - Svezia 1
TR - Turchia 1
UA - Ucraina 1
UG - Uganda 1
Totale 274
Città #
Dublin 46
Parma 33
Ann Arbor 12
Boardman 10
Ashburn 8
Medolla 7
Milan 5
Bremen 4
Dong Ket 4
Indianapolis 4
Detroit 3
Fleming Island 3
Hartford 3
Helsinki 3
Southend 3
Amstelveen 2
Carate Brianza 2
Casina 2
Central District 2
Council Bluffs 2
Delhi 2
Houston 2
Pune 2
Reggio Nell'emilia 2
Serra 2
Shanghai 2
Vienna 2
Yongsan 2
Ahmedabad 1
Atlanta 1
Bacoli 1
Bengaluru 1
Borås 1
Brooklyn 1
Cagliari 1
Casalgrande 1
Cincinnati 1
Fayetteville 1
Genoa 1
Harada 1
Lake Forest 1
Manipal 1
Milpitas 1
Minneapolis 1
Mumbai 1
Nam Định 1
Norwalk 1
Osaka 1
Oslo 1
Palo Alto 1
Paola 1
Paris 1
Reggio Emilia 1
Riyadh 1
Rockville 1
Rome 1
Santa Clara 1
Siena 1
Tokyo 1
Tübingen 1
Totale 206
Nome #
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib, file e177fbc7-275c-50b0-e053-d805fe0adaee 42
Pemetrexed enhances membrane PD-L1 expression and potentiates T cell-mediated cytotoxicity by anti-PD-L1 antibody therapy in non-small-cell lung cancer, file e177fbc6-c828-50b0-e053-d805fe0adaee 30
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells., file e177fbc5-d274-50b0-e053-d805fe0adaee 28
Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands, file e177fbc7-5309-50b0-e053-d805fe0adaee 25
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines, file e177fbc5-e007-50b0-e053-d805fe0adaee 22
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC, file e177fbc6-8be1-50b0-e053-d805fe0adaee 21
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines, file e177fbc4-3e0a-50b0-e053-d805fe0adaee 18
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines, file e177fbc5-2589-50b0-e053-d805fe0adaee 16
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines., file e177fbc6-8938-50b0-e053-d805fe0adaee 14
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells, file e177fbc6-9bb6-50b0-e053-d805fe0adaee 14
Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands, file e177fbc5-5fdc-50b0-e053-d805fe0adaee 11
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion, file e177fbc7-5975-50b0-e053-d805fe0adaee 11
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation, file e177fbc7-5aef-50b0-e053-d805fe0adaee 9
Targeting PI3K somatic mutations reduces invasion and EMT in squamous cell carcinoma of the lung, file e177fbc4-8054-50b0-e053-d805fe0adaee 4
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility, file e177fbc5-5718-50b0-e053-d805fe0adaee 2
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN, file e177fbc5-953c-50b0-e053-d805fe0adaee 2
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells, file e177fbc6-03ea-50b0-e053-d805fe0adaee 2
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation, file e177fbc7-56f9-50b0-e053-d805fe0adaee 2
Dual inhibition of CDK4/6 and PI3K/AKT/mTOR signaling impairs energy metabolism in MPM cancer cells, file e177fbc7-a024-50b0-e053-d805fe0adaee 2
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations., file e177fbc4-8faf-50b0-e053-d805fe0adaee 1
Totale 276
Categoria #
all - tutte 1.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.051


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 1 0 1 3 0 0 9
2021/202274 4 13 3 7 3 2 17 4 4 5 5 7
2022/2023120 9 2 2 2 8 4 5 8 52 2 17 9
2023/202459 8 5 5 10 0 3 17 9 2 0 0 0
Totale 276